This implies that passive immunization with tau antibodies is really a viable therapeutic target and which the CSF volume of p-tau262/356 or from the microtubule binding area (MTBD) can serve as a helpful biomarker of tau pathology to watch tau therapeutics in medical trials.Or you may invest in a pill, which is generally lesser and lighter than mo